While NICE guidelines are considered a high-quality source of evidence, they are not the sole determinant of treatment decisions
The Diversity Assumption Deserves a Second Look DCTs are often framed as a fix for clinical trial diversity, and traditional trials do have a real access problem one frequently cited (though dated) estimate suggests only around 5% of eligible patients participate in clinical research
Una fortaleza de nuestro estudio comparado con el de Aoun y sus colaboradores es que se consider desde un inicio que los participantes no estuvieran recibiendo tratamiento con hierro, lo cual pudo explicar la mejora observada en estos autores
Glucagon Like Peptide-1 is a single, non-glycosylated, polypeptide chain containing 30 amino acids and having a molecular mass of 3298.7 Dalton
In addition to these findings on atherosclerotic plaque formation, GLP-1R agonists prevented the increase in plasminogen activator inhibitor type-1 (PAI-1) and vascular cell adhesion molecule-1 (VCAM-1) gene expression in response to TNF- or hyperglycemia in HUVEC through PKA pathway [24],[70]
Tsatalis and A
